Entities / Company
Seres Therapeutics (United States).
company in Cambridge, United States
- Reports this week
- 0
- Active events
- 0
- Connections
- 23
What's happening
Gone quiet
No new reports in 90+ days-
Flagship Pioneering is the largest shareholder of Seres Therapeutics.Some support1 report
-
Seres Therapeutics announced that Eric Shaff stepped down as CEO and Marella Thorell was appointed co-CEO.Some support1 report
-
Seres Therapeutics received FDA input guiding its Phase 2 protocol, concurrent with Nestlé Health Science providing a $25 million installment payment.Some support2 reports
No events began in the chosen period. Widen it, or reset.
Around Seres Therapeutics (United States) this week
News at the entities that move Seres Therapeutics (United States) most-
FDA StructuralThe FDA approved Miplyffa for the treatment of Niemann-Pick disease.Moves Seres Therapeutics (United States)
-
Cambridge Shared contextArmenian Museum of America collaborated with a Cambridge-based firm in November 2026.Moves Seres Therapeutics (United States)
Connections
The 3 strongest of 23, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
FDA Structural
The FDA actively regulates, guides, and approves Seres Therapeutics' drug development and products.
-
Fast Track Structural
Seres Therapeutics received the Fast Track designation for its drug candidate SER-155.
-
Cambridge Shared context
Seres Therapeutics is located in Cambridge, Massachusetts.
History
Events by the month they beganJune 2026
3 events- Flagship Pioneering is the largest shareholder of Seres Therapeutics.
- Seres Therapeutics announced that Eric Shaff stepped down as CEO and Marella Thorell was appointed co-CEO.
- Seres Therapeutics received FDA input guiding its Phase 2 protocol, concurrent with Nestlé Health Science providing a $25 million installment payment.